website 720x480 px 2024 03 04T115524.333
04th March 2024

Kudun and Partners Assists Hausen Bernstein Co., Ltd. on a joint venture with Chemopharm SDN. BHD.

Kudun and Partners represented the sponsors and shareholders of Hausen Bernstein Co., Ltd., a Thailand-based healthcare ...

Read more
website 720x480 px 79
18th January 2023

Kudun and Partners successfully assisted Mindray Medical (Thailand) Limited in obtaining a foreign business license from the Ministry of Commerce for wholesale laboratory analytical and diagnostic reagents.

Kudun and Partners successfully assisted Mindray Medical (Thailand) Limited in obtaining a foreign business license from...

Read more
website 720x480 px 66
02nd November 2021

Meticuly raised series B funding to develop AI technology software to enhance patients’ personalized care.

Kudun and Partners represented Meticuly Co., Ltd. with respect to series B funding for AI technology software to design ...

Read more
website 720x480 px 61
21st October 2021

Thammasat University signs the licensing agreement with Antitoxin GmbH, Germany.

Kudun and Partners represented Thammasat University with the preparation of the licensing agreement with Antitoxin GmbH,...

Read more
website 720x480 px 50
27th August 2021

Perceptra Raised Seed Funding to Develop AI Technology For Assisting Doctors in Medical Diagnosis.

Kudun and Partners represented Perceptra with respect to seed fund raising to develop AI technology aiming to assist doc...

Read more
website 720x480 px 47
25th August 2021

My health group raised series A funding to develop AI technology for health care systems during the COVID-19 pandemic.

Kudun and Partners represented My Health Group with respect to series A funding for AI technology research, various sy...

Read more